2019
DOI: 10.1504/ijcbdd.2019.10025248
|View full text |Cite
|
Sign up to set email alerts
|

The potential inhibitory role of teucrolivins against human dipeptidyl peptidase 4 protein as a promising strategy for treatment of type 2 diabetes

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
1

Citation Types

0
1
0

Year Published

2020
2020
2023
2023

Publication Types

Select...
3

Relationship

0
3

Authors

Journals

citations
Cited by 3 publications
(1 citation statement)
references
References 0 publications
0
1
0
Order By: Relevance
“…To showcase the versatile and robust utility of our reaction in the rapid construction of diverse bridged and fused polycyclic scaffolds, we selected 2v , 2h , 2p and 4 g as examples and converted them into vital intermediates that are promising for the synthesis of bioactive natural products or functional materials (Scheme 2). First, the Bayer‐Villiger oxidation of 2 v afforded a lactone 6 , which is the main scaffold of neoclerodane diterpenoids [18] and has been used to treat type 2 diabetes [19] . Second, tricyclic structure 7 could be successively accessed from 2 h via IBX oxidation and an aldol reaction.…”
Section: Resultsmentioning
confidence: 99%
“…To showcase the versatile and robust utility of our reaction in the rapid construction of diverse bridged and fused polycyclic scaffolds, we selected 2v , 2h , 2p and 4 g as examples and converted them into vital intermediates that are promising for the synthesis of bioactive natural products or functional materials (Scheme 2). First, the Bayer‐Villiger oxidation of 2 v afforded a lactone 6 , which is the main scaffold of neoclerodane diterpenoids [18] and has been used to treat type 2 diabetes [19] . Second, tricyclic structure 7 could be successively accessed from 2 h via IBX oxidation and an aldol reaction.…”
Section: Resultsmentioning
confidence: 99%